Abstract
Invasive aspergillosis (IA), primarily caused by Aspergillus fumigatus, is an opportunistic fungal infection predominantly affecting immunocompromised and neutropenic patients that is difficult to treat and results in high mortality. Investigations of neutrophil-hypha interaction in vitro and in animal models of IA are limited by lack of temporal and spatial control over interactions. This study presents a new approach for studying neutrophil-hypha interaction at single cell resolution over time, which revealed an evasive fungal behavior triggered by interaction with neutrophils: Interacting hyphae performed de novo tip formation to generate new hyphal branches, allowing the fungi to avoid the interaction point and continue invasive growth. Induction of this mechanism was independent of neutrophil NADPH oxidase activity and neutrophil extracellular trap (NET) formation, but could be phenocopied by iron chelation and mechanical or physiological stalling of hyphal tip extension. The consequence of branch induction upon interaction outcome depends on the number and activity of neutrophils available: In the presence of sufficient neutrophils branching makes hyphae more vulnerable to destruction, while in the presence of limited neutrophils the interaction increases the number of hyphal tips, potentially making the infection more aggressive. This has direct implications for infections in neutrophil-deficient patients and opens new avenues for treatments targeting fungal branching.
Author Summary
For patients who have compromised immune systems, infection with yeasts and moulds are often deadly. To learn more about how immune cells fight fungal infection, we developed an “infection-on-a-chip” device, which allowed us to directly image interactions in real time. To our surprise, when immune cells attacked the fungi and stalled its growth, the fungi formed new branches, allowing it to avoid the interaction and continue growing. Our hypothesis is that in people with healthy immune cells, forcing the fungi to branch may make it more vulnerable to further attack. However, in patients with impaired immune systems, increasing the number of fungal branches may make the infection more aggressive. By developing new drugs that affect fungal branching, we may be able to give the immune cells of sick patients an advantage in their uphill battle against fungal infection.
Introduction
Aspergillus fumigatus is a filamentous, conidiating fungus ubiquitous to the environment. Airborne conidia are inhaled in the hundreds by individuals every day [1] and are quickly cleared by macrophages [2–4]. If not cleared, conidia grow into elongated hyphal structures, which present a unique challenge for the cellular immune system: Hyphae cannot be phagocytosed by immune cells, requiring deployment of extracellular antifungal mechanisms such as degranulation [5], production of extracellular reactive oxygen species (ROS) [6], secretion of ion-sequestering proteins such as Calprotectin [7] and Lactoferrin [8], and production of neutrophil extracellular traps (NETs) [9–11]. However, the fungus often overcomes these immune mechanisms and infections (aspergillosis) are frequent in particular immunosuppressed patients [12] and those suffering from chronic granulomatous disease (CGD) [13] or chronic obstructive pulmonary disease (COPD) [14]. The mechanisms by which Aspergillus can avoid both cellular and extracellular antifungal mechanisms are not well understood, hampering our ability to develop effective treatments to avoid aspergillosis in these patients [15].
The presence of dichotomously branched hyphae has long been used as a diagnostic indicator for invasive A. fumigatus infection [16]. It has been generally assumed that controlled branching enhances fungal invasion, as strains that exhibit perturbed branching behavior and irregular growth polarity exhibit reduced virulence in vivo [17–19]. Perturbed branching in these mutant strains is driven by altered ROS production or localization [20,21], calcium signalling [18,22], hypoxic stress responses [19], or cell wall synthesis pathways [23,24]. However, the study of host-hyphae interactions in vitro and in animal models of IA is limited by lack of control over the interactions and lack of methods to study these interactions at single cell resolution.
Microscale technologies, particularly microfluidic devices, are emerging as an important tool for ex vivo analysis of neutrophil biology [25]. Recent work has begun to explore the applicability of these devices to investigating host-pathogen interaction [26,27]. For example, work by our group recently demonstrated that migration along chemotactic gradients acts to prime neutrophils for antifungal activity against A. fumigatus [27], while others have used microfluidic techniques to identify immunosuppressive fungal metabolites [28]. For microbiologists, microfluidics has provided a useful platform for imaging active Candida hyphal growth at high resolution, revealing that internal polarity protein complexes are asymmetrically skewed toward softer substratum [29].
Here we present an in vitro microfluidic assay that enables us to study interactions between neutrophils and hyphae at cellular resolution over time. We designed microfluidic devices to confine the growing hyphae in linear channels, enabling high spatial and temporal resolution monitoring of growing hyphal tips. These new microfluidic devices facilitate live study of interactions in unprecedented detail. Key features of the microfluidic device include spatial control of hypha growth, allowing alignment of multiple hyphae in parallel lanes, as well as temporal and spatial control of interactions between hyphae and neutrophils, facilitating detailed imaging studies. Using the new tools, we systematically explored the mechanisms by which neutrophils trigger hyphal branching. Furthermore, we designed microfluidic devices to decouple branching from neutrophil interaction, using mechanical obstacles. This enabled us to quantify and compare the effect of neutrophils on hyphae at different stages of branching, from thick, primary hyphae through to thin, highly branched structures.
We find that A. fumigatus branching after interaction with human neutrophils is independent of neutrophil NADPH oxidase activity and NETosis, but can be phenocopied by iron chelation and mechanical or physiological stalling of hyphal tip extension. Evasive branching and the consequential increased number of hyphal tips can enable the fungus to continue growing aggressively in the presence of small numbers of neutrophils. However, in the presence of sufficient numbers of neutrophils, branching increases fungus vulnerability to neutrophil destruction. Our findings suggest that new approaches to controlling A. fumigatus infections in patients are possible, and provide a new set of tools to further explore these possibilities for drug discovery.
Results
De novo hyphal branching is stimulated by neutrophil-hypha interactions
To allow measurement of reproducible and controllable leukocyte-hypha interactions, we designed a microfluidic device to confine the growing hyphae along a single axis. The device consists of parallel channels with circular “swarming chambers” separating a fungal loading chamber from a neutrophil loading chamber (Fig 1A). The device is multiplexed to allow 12 fields of view per device. Moreover, the use of microfluidic devices for microscopy enabled high throughput and high-resolution imaging in a single plane (Fig 1A). Each viewing field accommodates 9 parallel interaction channels, allowing the potential for simultaneous capture of over 100 individual, interacting hyphae per condition, with 12 conditions tested per experiment. Conidia were seeded into the central chamber of the device (Fig 1Aii) and hyphae cultured for 18 hours, until they began entering the interaction channels (Fig 1Aiii). Hypha entered 4–5 of the 9 interaction channels on average (S1A Fig), with a slight bias observed toward the far viewing field, as might be expected for hyphae exhibiting primarily radial growth (S1A Fig). Chemical treatments could be administered throughout the entire device by loading through the central chamber, or selectively to the growing tips of the hypha by administering into the outer channel via the neutrophil loading port (Fig 1Ai).
Delivery of neutrophils into the outer channel was followed by migration down the interaction channels towards the growing hyphae (S1 Movie). Upon interaction of neutrophils with the hyphae, particularly when close to the growing tip, we observed an unexpected hyphal response: The hyphae formed new growth tips and branched, a phenotype we hypothesized to represent damage-induced “evasive branching” (Fig 1Ciii–1Civ, S2 Movie). Neutrophils engaged new hyphal tips and inhibited their growth, resulting in a transient decrease in leading tip velocity (Fig 2A). However, at least one hypha was almost always observed to avoid confrontation and continue penetrative growth (Fig 2Evi, S2 Movie).
The frequency of hyphal branching was proportional to the number of interacting neutrophils (Fig 2B), occurred proximally to sites of interaction (Fig 2C), and began shortly following initiation of the interaction (Fig 2D). During induction of apical branching, neutrophil interaction decreased the growth velocity of the leading hyphal tip, relative to the number of neutrophils involved (Fig 2A and 2E). To test the specificity of branch induction to neutrophil interaction, we repeated this assay using a range of other primary human immune cells: eosinophils; monocytes; monocyte-derived macrophages, and lymphocytes (Fig 2F and 2G). Although comparable numbers of each cell type were delivered, fewer interactions with hyphae were observed for these cells compared to neutrophils, as they exhibited little recruitment to fungal hyphae (Fig 2F). When they were observed to interact, apical branch induction occurred at less than half the rate for interaction with these cell types compared to neutrophils (Fig 2G), while induction of lateral branching was not observed at all. Together, these correlative observations strongly support a model in which hyphae form new branches in response to neutrophil interactions.
Induction of apical hyphal branching is independent of neutrophil NADPH activity and NETosis
Following delivery of neutrophils, robust antifungal responses were observed, including attachment of neutrophils both to the growing tip and along the length of hypha (Fig 3), formation of neutrophil swarms (Fig 3Aii), NETosis (Fig 3Cii) and generation of ROS (Fig 3Aiii and 3Ciii).
Given that neutrophil interaction induced formation of new hyphal tips, we hypothesized that this induction is dependent on neutrophil antimicrobial mechanisms. To test this hypothesis, we performed a series of experiments aimed at inhibiting or enhancing specific neutrophil functions.
Our previous studies demonstrated that neutrophils primed by an N-formyl-methionine-leucyl-phenylalanine (fMLP) gradient exhibited enhanced suppression of A. fumigatus growth [27]. Introduction of an fMLP gradient in the current study prior to delivery of neutrophils resulted in increased recruitment of neutrophils to sites of interaction (S1B Fig), an increase in hyphal exposure to NETs (Fig 4A), and increased fungal branching (Fig 4B). We therefore hypothesized that NETosis might be central to inducing hyphal branching.
Partial inhibition of NETosis has been demonstrated by reducing the activity of Neutrophil Elastase or Myeloperoxidase by pre-treatment Neutrophil Elastase inhibitor (NEi) or 4-aminobenzoic acid hydrazide (ABAH) respectively [8,30]. Pre-treatment of neutrophils with these chemicals did not significantly reduce NETosis or effect branching in this system (Fig 4A and 4B). Inhibition of NADPH oxidase using diphenyleneiodonium chloride (DPI) successfully abrogated the enhanced NETosis observed for fMLP-primed neutrophils (Fig 4A), but reducing NETosis in this manner appeared to have no effect on hyphal branch induction (Fig 4B). Degrading NETs using DNAse, one of the most robust methods of reducing NETs from healthy neutrophils [31,32], also failed to effect hyphal branch induction (Fig 4B), suggesting that branch induction occurs independently on NETosis.
Hyphal “hyperbranching” is induced by heat-labile plasma components
In a physiological setting, platelets have been demonstrated to coordinate with neutrophils to enhance antifungal activity [33]. To test whether this phenotype could be recapitulated in our system, autologous platelet poor plasma (PPP), platelet rich plasma (PRP), or washed platelets (WP) were added alone or immediately preceding neutrophil delivery. Strikingly, we observed robust stimulation of hyphal hyperbranching in response to exposure to PPP and PRP, but not WP, even in the absence of neutrophils (Fig 5A and 5B). Lack of hyperbranching in the acid citrate dextran (ACD)-containing media control and the WP group ruled out a role for ACD in induction of this response.
Induction of the hyperbranching response appeared to coincide with formation of cross-linked fibrin clots in the plasma groups (S3 Movie). To test whether clot formation was sufficient to induce hyphal branching, we spiked WP with fluorescently labelled Fibrinogen, which formed robust clots upon platelet activation by the hyphae. This treatment increased hyphal branching relative to the ACD control (Fig 5C). However, the non-clotting control treatment of Fibrinogen alone induced additional branching compared to the clotting treatment group, demonstrating that Fibrinogen alone is sufficient to induce branching and that formation of cross-linked fibrin clots was dispensable for this response (Fig 5C).
Plasma is a complex mix of proteins, peptides and various chemicals, some of which are stable at 56°C, such as Fibrinogen, and some of which are degraded, such as Complement factors. Treatment of hyphae with heat-treated (HT)-plasma did not induce hyperbranching (Fig 5C), ruling out endogenous Fibrinogen as the inducing factor present in plasma, and instead implicating a heat-labile component in this pathway.
Importantly, plasma-induced hyperbranching significantly attenuated leading tip velocity, relative to the number of branches produced (Fig 5C and 5D), suggesting a strong link between increased branching and decreased hyphal tip growth speed.
Apical branching can be induced by mechanical impedance of hyphal tip extension
The ability of non-commensal fungi to sense and avoid physical obstacles (thigmotropism) plays an important role in their hyphal growth in their primary environment, and is also implicated in virulence [34]. Since induction of branching was observed following decreased hyphal growth speed in response to increased neutrophil recruitment (Fig 2A, S2 Movie), we hypothesized that hypha might be responding to mechanical impedance of leading tip growth.
To test this hypothesis, we developed a new device that incorporated a range of physical obstacles into our microfluidic channels, designed to apply variable mechanical impedance to the growing tip upon contact. During interaction with the hypha tip, these obstacles induced apical branching similar to that observed during neutrophil interaction (Fig 6A and 6B), at a frequency relative to the ability of the obstacle to slow tip extension (Fig 6C and 6D). A crescent-shaped “tip-trap” obstacle, which efficiently slowed tip extension (Fig 6D and 6E) induced branching at a rate of more than 80% (Fig 6B and 6C, S4 Movie), demonstrating that physical stalling of tip extension is sufficient to induce hyphal branching.
Apical branching can be induced by thermally stalling hyphal tip extension
Since single neutrophils were observed to induce apical branching (Fig 6A) and seemed unlikely to be physically blocking hyphal extension, we hypothesized that they might instead induce branching by physiologically stalling tip extension.
To test whether physiologically stalling growth was sufficient to induce apical branching, we compared branching rates between actively growing hyphae and hyphae whose growth had been arrested by reducing the temperature to 4°C for 6 hours prior to imaging at 37°C (Fig 7A). To synchronize growth of control hyphae with the cold-paused group, control hyphae were also initially arrested at 4°C for 6 hours and then grown continuously. Upon resuming growth, a 3-fold increase in branching was observed for growth-arrested hypha (Fig 7B), confirming that stalling tip extension in the absence of mechanical impedance is sufficient to induce branching at the hypha tip.
Induction of hyphal branching can be phenocopied by chelation of iron
Neutrophil-derived lactoferrin has been shown to inhibit hyphal growth by chelation of iron [8]. To test whether iron chelation could induce branching, we exposed actively growing hyphae to non-specific (EDTA) and specific (hydroxybenzyl ethylenediamine—HBED, Lactoferrin) iron chelators (Fig 8). The addition of HBED resulted in a statistically significant increase in hyphal branching (Fig 8A), while treatment with EDTA or active Lactoferrin also significantly slowed hyphal tip growth and appeared to double average branching (from 0.26 to 0.56 and 0.48 branches/hypha/hour respectively, Fig 8). Importantly, Lactoferrin-induced growth inhibition was not observed for iron-saturated Lactoferrin (“Lactoferrin (Fe)”, Fig 8B), demonstrating that the growth inhibition effect of Lactoferrin treatment was dependent on its capacity to chelate iron.
Branch induction slows hypha growth and increases vulnerability to attack by human neutrophils
The robust branching frequency induced by the novel crescent-shaped “tip-trap” obstacle (Fig 6C, S4 Movie) facilitated measurement of the effect of branch induction on hyphal growth speed. By comparing hyphae during induction of sequential branching, we observed that tip velocity was reduced post-branch, relative to the number of times branches were induced (Fig 9Ai and 9Aii, S5 Movie).
This approach also enabled us to test the relationship between the degree of hyphal branching and the susceptibility of hypha to destruction by neutrophils. Addition of neutrophils to the device following induction of sequential branching demonstrated that neutrophils were better able to compromise the cell wall integrity of highly branched hyphae, as indicated by reduced time to loss of hyphal cytoplasmic EGFP fluorescence (Fig 9B and 9D, S6 Movie), likely due to their smaller diameter (Fig 9C and 9E).
Importantly, neutrophils with reduced capacity to produce ROS (DPI treated) and neutrophils isolated from at-risk patients (kidney transplant recipients receiving immunosuppressive therapy, S1 Table) were less efficient at killing primary hyphae, exhibiting 42% and 59% killing respectively, compared to 86–87% in control groups. The time required for killing was also increased, even for thin, highly branched hyphae generated using sequential mechanical branch induction (Fig 9F). These observations support a model in which induction of branching may inhibit hyphal infection by slowing hyphal penetration, and increase hyphal vulnerability to destruction by healthy neutrophils, so long as sufficient numbers of active neutrophils are present. However, if neutrophil numbers are insufficient, or their activity suppressed, branch induction provides an evasive mechanism by which hyphae can avoid neutrophil interaction to continue, and in some cases amplify, hyphal growth.
Discussion
Here we demonstrate that neutrophil-hypha interactions correlate with branching of Aspergillus fumigatus hyphae. The ability of neutrophils to pause hyphal tip extension is key to this fungal response. The response could be phenocopied by stalling of hyphal tip growth mechanically, thermally, and via chelation of iron.
Branching is associated with lower hyphal tip extension velocity, and results in thinner hyphae with increased surface area-to-volume ratios, although total fungal mass may not be affected. In the presence of excess neutrophils, thinner hyphae exhibit increased vulnerability to destruction. Mutations that induce constitutive hypha hyperbranching in A. fumigatus are associated with severe growth inhibition and decreased virulence in infection models [17–19], likely due to the slower speeds at which they are able to penetrate the tissue, and potentially an increased vulnerability to destruction. Induction of hyperbranching by plasma may provide a mechanism that sensitizes hypha to destruction by innate immune cells, but may also have negative implications for clot formation and blockage of vessels in infection [35–37]. Clot formation was robustly induced by hyphae in the presence of platelets and Fibrinogen, although formation of cross-linked Fibrin was dispensable for induction of branching. In the context of our iron chelation experiments, the ability of Fibrinogen alone to induce branching is likely linked to its activity as a iron-binding protein [38]. Identification of specific plasma factors that induce hyphal hyperbranching remains an interesting avenue for further research.
Our study expands upon the current understanding of the activity of neutrophils in aspergillosis. Neutrophils are assumed to be ineffective at killing phagocytosed conidia in vitro due to the tough outer coating [39] and because conidia appear to remain immunologically silent to neutrophils until they begin to germinate [40,41]. Observations are emerging suggesting that the primary role of neutrophils is to kill hyphae [42,43]. Working in concert with non-cellular immune components, such as platelets [33], defensins [44] and complement [45,46], extracellular neutrophil mechanisms act to restrict invasive growth and destroy hyphal structures.
This study has demonstrated that interaction with neutrophils induces loss of hyphal tip polarity and induction of de novo hyphal tip formation. Given that this effect could be phenocopied by chelation of iron, neutrophil-derived Lactoferrin is a good candidate to mediate this interaction. Neutrophil-derived Lactoferrin has previously been shown to inhibit conidial growth [8,47], but was not found to significantly affect hyphal viability [8]. However, hyphae exposed to human neutrophils show increased expression of ion-transporter catalysis mediators, including the 4-fold up-regulation of the ferric-chelate reductase Afu6g13750 [48]. Fungal ferric-chelate reductases are functionally homologous to components of the human NADPH oxidase complex [49], and are important for both iron acquisition and production of ROS. Given the central role of intracellular ROS in maintenance of hyphal tip polarity [20,21] and the role of ion sequestration in neutrophil suppression of fungal growth [7,50], the link between neutrophils, iron-sequestration, and loss of tip polarity is well supported.
Furthermore, localized extracellular ROS generated by neutrophils at sites of interaction along the length of the hyphae appeared to coincide with de novo tip formation in some instances (Fig 3C) suggesting a parallel pathway by which neutrophil interaction might induce localized re-polarization and lateral hyphal branch formation.
The current study was enabled by innovative microfluidic devices that allowed us to study interactions between neutrophils and fungal hyphae in unprecedented detail by: 1) Guiding the growth of individual hypha tips down parallel channels, allowing us to track hypha growth speed over defined distances; 2) Initiating interaction and branching with highly controlled temporal and spatial constrains; 3) Integration of imaging and biochemical assays; and 4) Providing a high-throughput system to trigger branching with utmost control over location, number, and timing of branching.
Although predominantly associated with diseases that suppress the immune system, opportunistic fungal infections are becoming an increasing problem in the clinic [51]. Modern medical treatments involving organ and bone marrow transplant rely heavily on immunosuppression of the patient to avoid tissue rejection and graft-versus-host disease. Although a direct effect of immunosuppressant therapy on neutrophil activity remains controversial, our previous studies indicate that neutrophils from these patients exhibit reduced activity against A. fumigatus [27]. Prophylactic treatment of immunosuppressed patients with broad-spectrum antibiotics, aimed at reducing risk of bacterial infection, is standard practice [52]. This not only encourages development of multidrug-resistant bacterial strains [53], but also affects commensal bacteria niches [54]. In combination with host immunosuppression, this scenario creates an environment permissive for opportunistic fungal infection [55–57].
Our studies indicate that, if insufficient neutrophil numbers are present, hyphal branching acts as an evasive maneuver, allowing the hyphae to continue penetrative growth past the interaction point. Given the susceptibility of neutropenic patients to fungal infection, these observations suggest that interacting with low neutrophil numbers may actually make the infection more aggressive by increasing the number of tissue-penetrating hyphal tips.
Although still relatively rare, rates of opportunistic fungal infection are steadily rising [51], and once established, infections are very difficult to treat [56]. Shared eukaryotic biology underpins the toxicity of many current antifungal medications to the host [58], while few attempts at development of new therapies have been made in the last decades [59].
The ability to modulate either neutrophil or hyphal behavior in the context of this interaction has direct relevance to the outcome of infection. Correction of neutrophil numbers or perhaps even stimulation of existing neutrophil functions in neutropenic patients is likely to improve outcome by increasing hyphae destruction. Similarly, blockage of de novo hyphal tip formation by targeting key fungal proteins such as WetA [60] may reduce hyphal virulence by reducing the number of hyphae for neutrophils to target. Conversely, induction of hyperbranching, such as can be achieved by targeting regulatory factors such as Calcineurin [61,62], may slow hyphal growth enough to allow destruction by neutrophils.
The assay we describe here may provide a high-throughput screening platform for identification of drugs affecting these important pathways. In particular, the novel “tip-trap” devices we present allow exceptional control over induction of hyphal branching, would be well suited to identification of compounds that inhibit de novo tip formation, and could be applied to a wide range of fungal species that exhibit hyphal growth.
Materials and Methods
Device design and fabrication
The microfluidic device was designed with three key elements, (1) the neutrophil loading ports and outer channel (Fig 1Ai, in purple), (2) the central conidia loading port and inner chambers (Fig 1Aii, in green) and (3) the neutrophil-hypha interaction channels (Fig 1Aiii). The twelve imaging fields on each device contain nine 10 x 675 μm interaction channels spaced 65 μm apart, each with seven 50 μm diameter swarming chambers spaced at 50 μm intervals.
Both the outer neutrophil loading channel and inner conidia port were fabricated at 50 μm depth, while the interaction channels at 10 μm depth to facilitate single-plane imaging.
The master wafer was fabricated using standard photolithographic technologies with Mylar photomasks (FineLine Imaging, Colorado Springs, CO). Polydimethylsiloxane (PDMS) (Sylgard 184, Elsworth Adhesives, Wilmington, MA) microfluidic devices were made by replica molding from the master wafer. Briefly, PDMS and curing agent were combined at a 10:1 ratio, mixed thoroughly, and poured over the master wafer. PDMS was then degassed for at least 30 min, then baked at 65°C for at least 3 hours. The PDMS was then peeled from the master wafer, and holes punched. The two outer neutrophil loading holes were punched with a 0.75 mm puncher, while the inner conidia loading port was punched using a 1.2 mm puncher. Each device was then cut out using an 8 mm puncher (Harris Uni-Core, Ted Pella Inc., Redding, CA). Following oxygen plasma treatment, devices and 12-well glass-bottom plates (MatTek Corp. Ashland, MA) were bonded at 85°C on a hotplate for 10 mins, and allowed to cool slowly.
Preparation of devices
One day prior to the experiment, devices were primed with Iscove’s Modified Dulbeco’s Medium (IMDM) with 20% fetal bovine serum (FBS) by loading the device with a gel-loading tip, inner port first followed by outer ports, such that media formed a dome on top of the device covering all three loading ports. Devices were subjected to vacuum for 10 mins, then allowed to re-pressurize for at least 20 mins, or until all air bubbles within the device were gone. The entire device was then submerged in media (2 mL per well in 12 well plate), and 0.5 μL of conidia (at 5 x 107 conidia/mL) loaded into the central port using a gel-loading tip, with care taken not to pipette into the surrounding media. Loaded devices were then incubated overnight, allowing germination of conidia and growth of hyphae into the outer chambers and interaction channels.
Once hyphae began to enter the interaction channels, neutrophils were delivered through the loading port and into the outer channels.
For N-formyl-Met-Leu-Phe (fMLP) experiments, fMLP (Sigma) at 100nM was delivered through the central loading port.
Immune cell preparation and treatments
Immune cells were isolated from human peripheral blood samples from healthy donors aged 21 years and older (Research Blood Components, LLC Allston, MA) drawn into 10 mL sodium heparin vacuum tubes (Vacutainer, Becton Dickinson). Nucleated cells were isolated by HetaSep gradient, then immune subsets were separated using EasySep kits from STEMCELL Technologies (Vancouver, Canada). Neutrophils were isolated using a Human Neutrophil Enrichment Kit, eosinophils with a Human Eosinophil Enrichment Kit, monocytes using a Human Monocyte Enrichment Kit, and lymphocytes using a Human Lymphocyte Enrichment Kit.
Human macrophages were differentiated from monocytes using standard techniques. Briefly: Monocytes were suspended in 1640 Roswell Park Memorial Institute medium (RPMI) and incubated for 2 hours at 37°C with 5% CO2 to allow monocyte adherence. After 2 hours, the non-adherent population was removed, and the remaining cells washed with ice cold Phosphate Buffered Saline (PBS) and trypsinized for 5 min at 37°C. Cells were then suspended in 1640 RPMI + 10% FBS medium containing Granulocyte macrophage colony-stimulating factor (GM-CSF), and incubated at 37°C with 5% CO2 for 24 hours. The GM-CSF medium was then replaced with 1640 RPMI with 1% Pen/Strep and 10% human serum (Sigma). Cells were maintained in 1640 RPMI with Pen/Strep and 10% human serum for 7 days with the medium changed every 3 days.
Prior to loading into the device, cells were typically stained with Hoechst 33342 (Life Technologies, Carlsbad, CA) according to the manufacturers protocol and re-suspended at 6 x 107 cells/mL in media. For imaging ROS, CellROX DeepRed reagent (ThermoFisher) was added at 12.5 μM to both to the media within the device and used to pre-stain neutrophils for 30 min prior to co-delivery with cells.
For all drug treatments, neutrophils were pre-treated for at least 30 mins with drug (diphenyleneiodonium chloride (DPI—Sigma) at 200 μM, 4-aminobenzoic hydrazide (ABAH—Sigma) at 500 μM, N-Methoxysuccinyl-Ala-Pro-Val-chloromethyl ketone (NEi—ThermoFisher) at 100 μM) and washed prior to delivery.
A. fumigatus preparation
A. fumigatus conidia of strain 293 expressing cytosolic EGFP of RFP were a kind gift from Jatin Vyas, prepared by Nida Khan using standard methods. Upon receipt, conidia were filtered using spin columns with 5 μm pores (Thermo Scientific) to isolate un-germinated spores and re-suspended at 5 x 107 conidia/mL in dH2O.
Plasma preparation and delivery
To prepare plasma fractions, including WP, PRP, and PPP, blood was collected from healthy volunteers in accordance with IRB protocols (2009-P-000295). Platelets were prepared from blood collected into 2.9 mL trisodium citrate Vacutainer tubes (Sarstedt, Nümbrecht, Germany). PRP was prepared by centrifugation of the whole blood at 210 g, 22°C, for 20 minutes. The PRP supernatant was gently pipetted into two tubes. In one tube, 20% volume acid citrate dextrose solution (ACD) (Boston Bioproducts Inc., Ashland, MA) was added and the PRP was incubated at 37°C until the start of the experiment. The second tube was centrifuged at 1900 g, 22°C, for 10 minutes. The PPP was removed, leaving a platelet pellet. IMDM with 20% FBS was used to re-suspend the platelet pellet, and ACD was added to the PPP and the platelet suspension. Platelets were stained with Calcein (Thermo Fisher Scientific Inc, Grand Island, NY). HT-plasma was prepared by heating PPP to 56°C for 30 mins. All plasma preparations were kept at 37°C until the start of the experiment.
Iron chelation
Iron chelation was achieved by delivering chelating treatments throughout the entire device, via the central port. EDTA (Sigma-Aldrich) was delivered at 10 μM, HBED (Santa Cruz Biotechnology) at 100 μM, and Lactoferrin groups at 100 μM. Human Lactoferrin derived from human breast milk was purchased from Sigma in both active and inactive (iron-saturated) forms.
Microscopy and analysis
All time-lapse imaging experiments were performed at 37°C with 5% carbon dioxide on a fully-automated Nikon TiE microscope, using a Plan Fluor 10x Ph1 DLL (NA = 0.3) lens. Image capture was performed using NIS-elements (Nikon Inc, Melville, NY) and analysis performed using FIJI (FIJI is just ImageJ, NIH) and Python scripts. NIS-elements and FIJI software were used to normalize the background color, and convert the file to an AVI. Python scripts used OpenCV (opencv.org) and TrackPy (http://soft-matter.github.io/trackpy/v0.3.0/) toolkits. OpenCV was used for background subtraction, automated cell counts and NET identification. A 5-frame rolling background filter was applied to remove cells that remained stationary for more than 10 mins from the tracking analysis. Tracks were based on relative velocity and position and informed by the inherent physical limitations imposed by the microfluidic channels. The TrackPy toolkit was used for cell tracking using the cells positions identified previously. Automated cell identification was based on cell size and shape, NET production was based on color and size, and hyphal tip velocity was measured by manually tracking tips in FIJI.
Statistics
Graphing and statistical analysis was performed using Prism (v6.0c, GraphPad Software Inc. La Jolla, CA). Statistical analysis included two-tailed Student’s t-tests for comparing pairs of normally distributed data, and one-way ANOVA with Tukey’s post hoc test for comparing datasets containing multiple treatment groups.
Ethics statement
Samples from kidney transplant patients (S1 Table) were collected at the Massachusetts General Hospital (MGH) with informed consent and IRB approval under protocol number 2009-P-002826.
Supporting Information
Acknowledgments
The authors would like to acknowledge the help of Octavio Hurtado and Arvind Chandrasekaran in microfluidic design and fabrication, and Mary Elizabeth Bilodeu for coordinating collection of patient samples. We would also like to thank Kevin Forrest, Martin Springer and Jim Balkovec for helpful discussions, and Prof Jatin Vyas and Nida Khan for supplying A. fumigatus conidia.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
Funding support for this project was provided in part by Cidara Therapeutics and grants from the National Institute of Health: EB002503 and GM092804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Latge JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12: 310–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, et al. (2003) Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 71: 891–903. 10.1128/IAI.71.2.891-903.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Philippe B, Ibrahim-Granet O, Prevost MC, Gougerot-Pocidalo MA, Sanchez Perez M, et al. (2003) Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 71: 3034–3042. 10.1128/IAI.71.6.3034-3042.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Schaffner A, Douglas H, Braude AI, Davis CE (1983) Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun 42: 1109–1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Levitz SM, Farrell TP (1990) Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leukoc Biol 47: 170–175. [DOI] [PubMed] [Google Scholar]
- 6.Boyle KB, Stephens LR, Hawkins PT (2012) Activation of the neutrophil NADPH oxidase by Aspergillus fumigatus. Ann N Y Acad Sci 1273: 68–73. 10.1111/j.1749-6632.2012.06821.x [DOI] [PubMed] [Google Scholar]
- 7.Clark HL, Jhingran A, Sun Y, Vareechon C, de Jesus Carrion S, et al. (2016) Zinc and Manganese Chelation by Neutrophil S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and Corneal Infection. J Immunol 196: 336–344. 10.4049/jimmunol.1502037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gazendam RP, van Hamme JL, Tool AT, Hoogenboezem M, van den Berg JM, et al. (2016) Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects. J Immunol 196: 1272–1283. 10.4049/jimmunol.1501811 [DOI] [PubMed] [Google Scholar]
- 9.Bruns S, Kniemeyer O, Hasenberg M, Aimanianda V, Nietzsche S, et al. (2010) Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog 6: e1000873 10.1371/journal.ppat.1000873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.McCormick A, Heesemann L, Wagener J, Marcos V, Hartl D, et al. (2010) NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect 12: 928–936. 10.1016/j.micinf.2010.06.009 [DOI] [PubMed] [Google Scholar]
- 11.Hopke A, Nicke N, Hidu EE, Degani G, Popolo L, et al. (2016) Neutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and Altered Immune Recognition. PLoS Pathog 12: e1005644 10.1371/journal.ppat.1005644 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Garcia-Vidal C, Upton A, Kirby KA, Marr KA (2008) Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 47: 1041–1050. 10.1086/591969 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Segal BH, Romani LR (2009) Invasive aspergillosis in chronic granulomatous disease. Med Mycol 47 Suppl 1: S282–290. [DOI] [PubMed] [Google Scholar]
- 14.Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, et al. (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16: 870–877. 10.1111/j.1469-0691.2009.03015.x [DOI] [PubMed] [Google Scholar]
- 15.Ben-Ami R, Lewis RE, Kontoyiannis DP (2010) Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol 150: 406–417. 10.1111/j.1365-2141.2010.08283.x [DOI] [PubMed] [Google Scholar]
- 16.Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5: 609–622. 10.1016/S1473-3099(05)70238-3 [DOI] [PubMed] [Google Scholar]
- 17.Gehrke A, Heinekamp T, Jacobsen ID, Brakhage AA (2010) Heptahelical receptors GprC and GprD of Aspergillus fumigatus Are essential regulators of colony growth, hyphal morphogenesis, and virulence. Appl Environ Microbiol 76: 3989–3998. 10.1128/AEM.00052-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Steinbach WJ, Cramer RA Jr., Perfect BZ, Asfaw YG, Sauer TC, et al. (2006) Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 5: 1091–1103. 10.1128/EC.00139-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Willger SD, Puttikamonkul S, Kim KH, Burritt JB, Grahl N, et al. (2008) A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog 4: e1000200 10.1371/journal.ppat.1000200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Semighini CP, Harris SD (2008) Regulation of apical dominance in Aspergillus nidulans hyphae by reactive oxygen species. Genetics 179: 1919–1932. 10.1534/genetics.108.089318 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li H, Barker BM, Grahl N, Puttikamonkul S, Bell JD, et al. (2011) The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus. Eukaryot Cell 10: 174–186. 10.1128/EC.00288-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.da Silva Ferreira ME, Heinekamp T, Hartl A, Brakhage AA, Semighini CP, et al. (2007) Functional characterization of the Aspergillus fumigatus calcineurin. Fungal Genet Biol 44: 219–230. 10.1016/j.fgb.2006.08.004 [DOI] [PubMed] [Google Scholar]
- 23.Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, et al. (1994) Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 38: 1480–1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mellado E, Dubreucq G, Mol P, Sarfati J, Paris S, et al. (2003) Cell wall biogenesis in a double chitin synthase mutant (chsG-/chsE-) of Aspergillus fumigatus. Fungal Genet Biol 38: 98–109. [DOI] [PubMed] [Google Scholar]
- 25.Irimia D, Ellett F (2016) Big insights from small volumes: deciphering complex leukocyte behaviors using microfluidics. J Leukoc Biol. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Moussavi-Harami SF, Mladinich KM, Sackmann EK, Shelef MA, Starnes TW, et al. (2016) Microfluidic device for simultaneous analysis of neutrophil extracellular traps and production of reactive oxygen species. Integr Biol (Camb) 8: 243–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jones CN, Dimisko L, Forrest K, Judice K, Poznansky MC, et al. (2016) Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus. J Infect Dis 213: 465–475. 10.1093/infdis/jiv419 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Berthier E, Lim FY, Deng Q, Guo CJ, Kontoyiannis DP, et al. (2013) Low-volume toolbox for the discovery of immunosuppressive fungal secondary metabolites. PLoS Pathog 9: e1003289 10.1371/journal.ppat.1003289 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Thomson DD, Wehmeier S, Byfield FJ, Janmey PA, Caballero-Lima D, et al. (2015) Contact-induced apical asymmetry drives the thigmotropic responses of Candida albicans hyphae. Cell Microbiol 17: 342–354. 10.1111/cmi.12369 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Metzler KD, Goosmann C, Lubojemska A, Zychlinsky A, Papayannopoulos V (2014) A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep 8: 883–896. 10.1016/j.celrep.2014.06.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, et al. (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176: 231–241. 10.1083/jcb.200606027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, et al. (2010) Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 584: 3193–3197. 10.1016/j.febslet.2010.06.006 [DOI] [PubMed] [Google Scholar]
- 33.Christin L, Wysong DR, Meshulam T, Hastey R, Simons ER, et al. (1998) Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 66: 1181–1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Brand A (2012) Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol 2012: 517529 10.1155/2012/517529 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Rose HD, Stuart JL (1976) Mycotic aneurysm of the thoracic aorta caused by Aspergillus fumigatus. Chest 70: 81–84. [DOI] [PubMed] [Google Scholar]
- 36.McCulloch E, Ramage G, Jones B, Warn P, Kirkpatrick WR, et al. (2009) Don't throw your blood clots away: use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosis. J Clin Pathol 62: 539–541. 10.1136/jcp.2008.063321 [DOI] [PubMed] [Google Scholar]
- 37.Kamai Y, Chiang LY, Lopes Bezerra LM, Doedt T, Lossinsky AS, et al. (2006) Interactions of Aspergillus fumigatus with vascular endothelial cells. Med Mycol 44 Suppl 1: S115–117. [DOI] [PubMed] [Google Scholar]
- 38.Orino K (2013) Functional binding analysis of human fibrinogen as an iron- and heme-binding protein. Biometals 26: 789–794. 10.1007/s10534-013-9657-8 [DOI] [PubMed] [Google Scholar]
- 39.Levitz SM, Diamond RD (1985) Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. J Infect Dis 152: 33–42. [DOI] [PubMed] [Google Scholar]
- 40.Knox BP, Deng Q, Rood M, Eickhoff JC, Keller NP, et al. (2014) Distinct innate immune phagocyte responses to Aspergillus fumigatus conidia and hyphae in zebrafish larvae. Eukaryot Cell 13: 1266–1277. 10.1128/EC.00080-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schaffner A, Douglas H, Braude A (1982) Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 69: 617–631. 10.1172/JCI110489 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Behnsen J, Narang P, Hasenberg M, Gunzer F, Bilitewski U, et al. (2007) Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathog 3: e13 10.1371/journal.ppat.0030013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sturtevant J, Latge JP (1992) Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. J Infect Dis 166: 580–586. [DOI] [PubMed] [Google Scholar]
- 44.Alekseeva L, Huet D, Femenia F, Mouyna I, Abdelouahab M, et al. (2009) Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 9: 33 10.1186/1471-2180-9-33 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Braem SG, Rooijakkers SH, van Kessel KP, de Cock H, Wosten HA, et al. (2015) Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation. J Innate Immun 7: 364–374. 10.1159/000369493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kozel TR, Wilson MA, Farrell TP, Levitz SM (1989) Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 57: 3412–3417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI (2007) Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 178: 6367–6373. [DOI] [PubMed] [Google Scholar]
- 48.Sugui JA, Kim HS, Zarember KA, Chang YC, Gallin JI, et al. (2008) Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One 3: e2655 10.1371/journal.pone.0002655 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Roman DG, Dancis A, Anderson GJ, Klausner RD (1993) The fission yeast ferric reductase gene frp1+ is required for ferric iron uptake and encodes a protein that is homologous to the gp91-phox subunit of the human NADPH phagocyte oxidoreductase. Mol Cell Biol 13: 4342–4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Leal SM Jr., Roy S, Vareechon C, Carrion S, Clark H, et al. (2013) Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum. PLoS Pathog 9: e1003436 10.1371/journal.ppat.1003436 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Enoch DA, Ludlam HA, Brown NM (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55: 809–818. 10.1099/jmm.0.46548-0 [DOI] [PubMed] [Google Scholar]
- 52.Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers W (2005) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189: 395–404. 10.1016/j.amjsurg.2005.01.015 [DOI] [PubMed] [Google Scholar]
- 53.O'Brien TF (2002) Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 34 Suppl 3: S78–84. [DOI] [PubMed] [Google Scholar]
- 54.Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, et al. (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120: 4332–4341. 10.1172/JCI43918 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, et al. (1983) Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 198: 622–629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kusne S, Torre-Cisneros J, Manez R, Irish W, Martin M, et al. (1992) Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 166: 1379–1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Dunn DL (2000) Diagnosis and treatment of opportunistic infections in immunocompromised surgical patients. Am Surg 66: 117–125. [PubMed] [Google Scholar]
- 58.Denning DW, Hope WW (2010) Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 18: 195–204. 10.1016/j.tim.2010.02.004 [DOI] [PubMed] [Google Scholar]
- 59.Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH (2010) An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 9: 719–727. 10.1038/nrd3074 [DOI] [PubMed] [Google Scholar]
- 60.Tao L, Yu JH (2011) AbaA and WetA govern distinct stages of Aspergillus fumigatus development. Microbiology 157: 313–326. 10.1099/mic.0.044271-0 [DOI] [PubMed] [Google Scholar]
- 61.Fortwendel JR, Juvvadi PR, Pinchai N, Perfect BZ, Alspaugh JA, et al. (2009) Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother 53: 476–482. 10.1128/AAC.01154-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Juvvadi PR, Steinbach WJ (2015) Calcineurin Orchestrates Hyphal Growth, Septation, Drug Resistance and Pathogenesis of Aspergillus fumigatus: Where Do We Go from Here? Pathogens 4: 883–893. 10.3390/pathogens4040883 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.